Viatris
Search results
Jul 11, 2024 · Our broad portfolio of approximately 280+ generic and specialty pharmaceuticals is the foundation from which we make healthy possible. And we expanded our portfolios to institutions, in biosimilars and across select international markets.
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a fully integrated global essential medicines company powered by a robust U.S. generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets.
Since 2008, we’ve been producing medicines for the U.S. market – a global leader and the gold standard in pharmaceutical quality. Today we’re bringing that same Amneal quality commitment to India patients and families.
About. AboutWe challenge convention so healthy can be possible. Our Story. Amneal at-a-glance. Our Founders. Our Milestones. Our Purpose & Commitments. Our Culture. Rise, Lead, Succeed.
Amneal Pharmaceuticals, Inc. is an American publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey . [2]
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is a U.S.-based fully integrated global essential medicines company powered by a robust generics business and a growing branded business as well as deepening portfolios in institutional injectables, biosimilars and select international markets including India.
We make healthy possible. | Amneal (NASDAQ: AMRX) is rapidly becoming one of the most dynamic, purpose-driven pharmaceutical companies delivering more affordable access to essential medicines.
Amneal is a global, diversified pharmaceutical company that provides access to high-quality, affordable, and essential medicines. Press Releases Stock Information
May 27, 2022 · BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s Biologics License Application (“BLA”) for pegfilgrastim-pbbk, a biosimilar referencing Neulasta ®. The product will be ...
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products...
